A detailed history of Lockheed Martin Investment Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Lockheed Martin Investment Management CO holds 16,780 shares of LLY stock, worth $12.6 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
16,780
Previous 2,500 571.2%
Holding current value
$12.6 Million
Previous $2.26 Million 556.92%
% of portfolio
0.69%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $11 Million - $13.7 Million
14,280 Added 571.2%
16,780 $14.9 Million
Q2 2024

Aug 07, 2024

BUY
$724.87 - $909.04 $1.81 Million - $2.27 Million
2,500 New
2,500 $2.26 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lockheed Martin Investment Management CO Portfolio

Follow Lockheed Martin Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lockheed Martin Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Lockheed Martin Investment Management CO with notifications on news.